Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +751.11%
#3 ADO Protocol ADO Protocol +101.14%
#4 Cortex Cortex +92.99%
#5 Ontology Gas Ontology Gas +77.68%
#6 Kinesis Silver Kinesis Silver +54.16%
#7 OpenEden OpenEden +35.10%
#8 Biconomy Biconomy +28.11%
#9 Magma Finance Magma Finance +26.20%
#10 QuantixAI QuantixAI +23.21%
Coin of the day
Black Phoenix Black Phoenix
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Flerie AB (publ) Flerie AB (publ)

Flerie AB (publ)

FLERIE
Kedudukan dalam Saham #18881
Flerie AB (publ) functions as a venture capital entity, concentrating its... Flerie AB (publ) functions as a venture capital entity, concentrating its investments on nascent businesses. The firm actively seeks to fund biotechnology and pharmaceutical companies dedicated to advancing drug discovery and development, or producing innovative tools and applications aimed at addressing pressing global health concerns. Geographically, their investment scope includes Europe, the United States, and Israel. Founded in 2011, Flerie AB (publ) is headquartered in Stockholm, Sweden, and also operates a branch office in London, United Kingdom.
Harga Saham
$2.11
Modal Pasaran
$183.02M
Perubahan (1 hari)
-1.82%
Perubahan (1 tahun)
-45.27%
Negara
SE
Perdagangan Flerie AB (publ) (FLERIE)

Kategori

Healthcare
Sejarah harga saham bagi Flerie AB (publ) (FLERIE)
Harga penutupan tertinggi: $2.21 pada 2026-08-01

Harga penutupan terendah: $4.24 pada 2024-06-01
Sejarah harga saham Flerie AB (publ) dari 2024 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -7.90%
2025 -7.26%
2024 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $1.20K 62.79%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $270.18 53.09%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $260.78 25.16%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $487.19 44.15%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $153.58 80.70%
US